SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001213900-24-004172
Filing Date
2024-01-17
Accepted
2024-01-17 16:30:12
Documents
18
Period of Report
2024-01-17
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 3.02: Unregistered Sales of Equity Securities
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 CURRENT REPORT ea191664-8k_abvcbio.htm   iXBRL 8-K 49588
2 SECURITIES PURCHASE AGREEMENT ea191664ex10-1_abvcbio.htm EX-10.1 275315
3 FORM OF NOTE ea191664ex10-2_abvcbio.htm EX-10.2 121817
4 FORM OF WARRANT ea191664ex10-3_abvcbio.htm EX-10.3 90086
5 SECOND AMENDMENT TO SECURITY AGREEMENT ea191664ex10-4_abvcbio.htm EX-10.4 15442
6 SECOND AMENDMENT TO GUARANTOR SECURITY AGREEMENT ea191664ex10-5_abvcbio.htm EX-10.5 19536
7 SECOND AMENDMENT TO GUARANTY ea191664ex10-6_abvcbio.htm EX-10.6 18529
  Complete submission text file 0001213900-24-004172.txt   893234

Data Files

Seq Description Document Type Size
8 XBRL SCHEMA FILE abvc-20240117.xsd EX-101.SCH 3021
9 XBRL LABEL FILE abvc-20240117_lab.xml EX-101.LAB 34240
10 XBRL PRESENTATION FILE abvc-20240117_pre.xml EX-101.PRE 22363
12 EXTRACTED XBRL INSTANCE DOCUMENT ea191664-8k_abvcbio_htm.xml XML 3216
Mailing Address 44370 OLD WARM SPRINGS BLVD. FREMONT CA 94538
Business Address 44370 OLD WARM SPRINGS BLVD. FREMONT CA 94538 510-668-0881
ABVC BIOPHARMA, INC. (Filer) CIK: 0001173313 (see all company filings)

IRS No.: 260014658 | State of Incorp.: NV | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-40700 | Film No.: 24538800
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)